Circulating levels of GDF-15 and calprotectin for prediction of in-hospital mortality in COVID-19 patients: A case series.
作者信息
Mulero María Dolores Rodríguez, Olivo Marta Hernández, Rojas Carlos Rodríguez, Arenas Verónica Ramos, Morales Mercedes González, Abellán Ana Blazquez, Conesa-Zamora Pablo, García-García Josefina, Hernández Andrés Conesa, Morell-García Daniel, Dolores Albaladejo-Otón María, Consuegra-Sánchez Luciano
机构信息
Medicine Laboratory Department, Hospital Universitario Santa Lucía, Cartagena, Spain. C/ Mezquita, s/n, Paraje Los Arcos, Cartagena, Santa Lucía 30202, Spain.
Intensive Care Unit, Hospital Universitario Santa Lucía, Cartagena, Spain. C/ Mezquita, s/n, Paraje Los Arcos, Cartagena, Santa Lucía 30202, Spain.
出版信息
J Infect. 2021 Feb;82(2):e40-e42. doi: 10.1016/j.jinf.2020.08.010. Epub 2020 Aug 12.
Abstract
摘要
相似文献
1
Circulating levels of GDF-15 and calprotectin for prediction of in-hospital mortality in COVID-19 patients: A case series.循环中生长分化因子-15和钙卫蛋白水平对预测COVID-19患者院内死亡率的研究：病例系列
J Infect. 2021 Feb;82(2):e40-e42. doi: 10.1016/j.jinf.2020.08.010. Epub 2020 Aug 12.
2
Circulating calprotectin as a supporting inflammatory marker in discriminating SARS-CoV-2 infection: an observational study.循环钙卫蛋白作为鉴别 SARS-CoV-2 感染的支持性炎症标志物：一项观察性研究。
Inflamm Res. 2021 Jun;70(6):687-694. doi: 10.1007/s00011-021-01465-y. Epub 2021 May 6.
3
Growth Differentiation Factor 15 Provides Prognostic Information Superior to Established Cardiovascular and Inflammatory Biomarkers in Unselected Patients Hospitalized With COVID-19.生长分化因子 15 为新冠肺炎住院患者提供比传统心血管和炎症生物标志物更好的预后信息。
Circulation. 2020 Dec;142(22):2128-2137. doi: 10.1161/CIRCULATIONAHA.120.050360. Epub 2020 Oct 15.
4
Dok3 restrains neutrophil production of calprotectin during TLR4 sensing of SARS-CoV-2 spike protein.Dok3 可在 TLR4 识别 SARS-CoV-2 刺突蛋白期间抑制中性粒细胞钙卫蛋白的产生。
Front Immunol. 2022 Sep 12;13:996637. doi: 10.3389/fimmu.2022.996637. eCollection 2022.
5
High fecal calprotectin levels are associated with SARS-CoV-2 intestinal shedding in COVID-19 patients: A proof-of-concept study.粪便钙卫蛋白水平高与 COVID-19 患者的 SARS-CoV-2 肠道脱落有关：一项概念验证研究。
World J Gastroenterol. 2021 Jun 14;27(22):3130-3137. doi: 10.3748/wjg.v27.i22.3130.
6
Assessment of antiphospholipid antibodies and calprotectin as biomarkers for discriminating mild from severe COVID-19.评估抗磷脂抗体和钙卫蛋白作为鉴别轻症与重症 COVID-19 的生物标志物。
J Clin Lab Anal. 2021 Nov;35(11):e24004. doi: 10.1002/jcla.24004. Epub 2021 Oct 5.
7
Outcome prediction by serum calprotectin in patients with COVID-19 in the emergency department.急诊科中血清钙卫蛋白对新型冠状病毒肺炎患者的预后预测
J Infect. 2021 Apr;82(4):84-123. doi: 10.1016/j.jinf.2020.11.016. Epub 2020 Nov 17.
8
Faecal calprotectin as a potential biomarker of disease severity in SARS-CoV-2 infection.粪便钙卫蛋白作为新型冠状病毒感染中疾病严重程度的潜在生物标志物。
J Infect. 2022 Oct;85(4):436-480. doi: 10.1016/j.jinf.2022.06.016. Epub 2022 Jun 26.
9
Serum calprotectin as a novel biomarker for severity of COVID-19 disease.血清钙卫蛋白可作为 COVID-19 疾病严重程度的新型生物标志物。
Ir J Med Sci. 2022 Feb;191(1):59-64. doi: 10.1007/s11845-021-02565-8. Epub 2021 Feb 27.
10
Elevated level of circulating calprotectin correlates with severity and high mortality in patients with COVID-19.循环钙卫蛋白水平升高与 COVID-19 患者的严重程度和高死亡率相关。
Immun Inflamm Dis. 2024 Mar;12(3):e1212. doi: 10.1002/iid3.1212.
引用本文的文献
1
Blood calprotectin as a biomarker for infection and sepsis - the prospective CASCADE trial.血液钙卫蛋白作为感染和脓毒症的生物标志物 - 前瞻性 CASCADE 试验。
BMC Infect Dis. 2024 May 16;24(1):496. doi: 10.1186/s12879-024-09394-x.
2
Proteomics validate circulating GDF-15 as an independent biomarker for COVID-19 severity.蛋白质组学验证了循环 GDF-15 是 COVID-19 严重程度的独立生物标志物。
Front Immunol. 2024 Apr 15;15:1377126. doi: 10.3389/fimmu.2024.1377126. eCollection 2024.
3
GDF-15 Levels and Other Laboratory Findings as Predictors of COVID-19 Severity and Mortality: A Pilot Study.生长分化因子-15水平及其他实验室检查结果作为COVID-19严重程度和死亡率预测指标的初步研究
Biomedicines. 2024 Mar 29;12(4):757. doi: 10.3390/biomedicines12040757.
4
Growth differentiation factor-15, a novel systemic biomarker of oxidative stress, inflammation, and cellular aging: Potential role in cardiovascular diseases.生长分化因子-15，一种氧化应激、炎症和细胞衰老的新型全身生物标志物：在心血管疾病中的潜在作用。
Am Heart J Plus. 2021 Aug 28;9:100046. doi: 10.1016/j.ahjo.2021.100046. eCollection 2021 Sep.
5
Elevated level of circulating calprotectin correlates with severity and high mortality in patients with COVID-19.循环钙卫蛋白水平升高与 COVID-19 患者的严重程度和高死亡率相关。
Immun Inflamm Dis. 2024 Mar;12(3):e1212. doi: 10.1002/iid3.1212.
6
Serum growth differentiation factor-15 (GDF-15) is a biomarker of cardiac manifestations in children with COVID-19.血清生长分化因子 15（GDF-15）是 COVID-19 患儿心脏表现的生物标志物。
Eur J Med Res. 2023 Nov 16;28(1):527. doi: 10.1186/s40001-023-01514-8.
7
Elevated Level of Circulating but Not Urine S100A8/A9 Identifies Poor COVID-19 Outcomes.循环 S100A8/A9 水平升高而非尿液 S100A8/A9 水平升高可识别 COVID-19 不良结局。
ACS Infect Dis. 2023 Oct 13;9(10):1815-1820. doi: 10.1021/acsinfecdis.3c00249. Epub 2023 Oct 3.
8
Cardiac Biomarkers and Their Role in Identifying Increased Risk of Cardiovascular Complications in COVID-19 Patients.心脏生物标志物及其在识别 COVID-19 患者心血管并发症风险增加中的作用。
Diagnostics (Basel). 2023 Jul 27;13(15):2508. doi: 10.3390/diagnostics13152508.
9
Core mitochondrial genes are down-regulated during SARS-CoV-2 infection of rodent and human hosts.核心线粒体基因在 SARS-CoV-2 感染啮齿动物和人类宿主时被下调。
Sci Transl Med. 2023 Aug 9;15(708):eabq1533. doi: 10.1126/scitranslmed.abq1533.
10
Organokines in COVID-19: A Systematic Review.COVID-19 中的器官激酶：系统评价。
Cells. 2023 May 9;12(10):1349. doi: 10.3390/cells12101349.
本文引用的文献
1
Neutrophil calprotectin identifies severe pulmonary disease in COVID-19.中性粒细胞钙卫蛋白可识别 COVID-19 中的严重肺部疾病。
J Leukoc Biol. 2021 Jan;109(1):67-72. doi: 10.1002/JLB.3COVCRA0720-359R. Epub 2020 Sep 1.
2
Serum ferritin as an independent risk factor for severity in COVID-19 patients.血清铁蛋白作为新冠病毒肺炎患者病情严重程度的独立危险因素。
J Infect. 2020 Oct;81(4):647-679. doi: 10.1016/j.jinf.2020.06.053. Epub 2020 Jun 24.
3
Growth/Differentiation Factor-15 (GDF-15): From Biomarker to Novel Targetable Immune Checkpoint.生长/分化因子 15（GDF-15）：从生物标志物到新型可靶向免疫检查点。
Front Immunol. 2020 May 19;11:951. doi: 10.3389/fimmu.2020.00951. eCollection 2020.
4
Molecular, serological, and biochemical diagnosis and monitoring of COVID-19: IFCC taskforce evaluation of the latest evidence.新型冠状病毒肺炎的分子、血清学和生化诊断与监测：国际临床化学和检验医学联合会专家组对最新证据的评估。
Clin Chem Lab Med. 2020 Jun 25;58(7):1037-1052. doi: 10.1515/cclm-2020-0722.
5
Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages.COVID-19 患者的病理性炎症：单核细胞和巨噬细胞的关键作用。
Nat Rev Immunol. 2020 Jun;20(6):355-362. doi: 10.1038/s41577-020-0331-4. Epub 2020 May 6.
6
The trinity of COVID-19: immunity, inflammation and intervention.COVID-19 的三位一体：免疫、炎症和干预。
Nat Rev Immunol. 2020 Jun;20(6):363-374. doi: 10.1038/s41577-020-0311-8. Epub 2020 Apr 28.
7
Serum Amyloid A is a biomarker of severe Coronavirus Disease and poor prognosis.血清淀粉样蛋白 A 是严重冠状病毒病和预后不良的生物标志物。
J Infect. 2020 Jun;80(6):646-655. doi: 10.1016/j.jinf.2020.03.035. Epub 2020 Apr 8.
8
S100A8/A9 in Inflammation.S100A8/A9 在炎症中的作用。
Front Immunol. 2018 Jun 11;9:1298. doi: 10.3389/fimmu.2018.01298. eCollection 2018.
9
Overproduction of growth differentiation factor 15 promotes human rhinovirus infection and virus-induced inflammation in the lung.生长分化因子 15 过度表达促进人类鼻病毒感染和病毒诱导的肺部炎症。
Am J Physiol Lung Cell Mol Physiol. 2018 Mar 1;314(3):L514-L527. doi: 10.1152/ajplung.00324.2017. Epub 2017 Nov 30.
10
S100A8/A9: From basic science to clinical application.S100A8/A9：从基础科学到临床应用。
Pharmacol Ther. 2016 Nov;167:120-131. doi: 10.1016/j.pharmthera.2016.07.015. Epub 2016 Aug 1.
Zotero 插件